Who uses Bruker CosMx?
CosMx is an in situ imaging platform that counts thousands of RNAs, or dozens of proteins, inside single cells in a tissue section. It's made by Bruker Spatial Biology (formerly NanoString). 101 bioRxiv and medRxiv preprints since April 2025 say they used CosMx, 37 in the last 6 months. Updated daily (as of Nov 16)
Is CosMx use still growing?
Yes: 37 preprints used CosMx in Jun–Nov 2026, +27% vs the previous year as a share of all preprints. This is slower than spatial biology platforms overall (+35%).
The last bar is the quarter so far. The % over each year compares it with the year before, as a share of all preprints.
How does CosMx compare with other spatial biology platforms?
CosMx is fifth, with 8% of their uses in Jun–Nov 2026, about the same as the year before. Visium leads with 37%.
Which institutions use CosMx most?
The institutions using CosMx most are Stanford University, Imperial College London and University of Georgia.
Institutions
Stanford University6
Imperial College London4
- University of Georgia3
University of Pennsylvania3
University of California, Los Angeles3
Where the labs are
The lab's institution and country are the corresponding author's.
Rival platforms, head to head
Latest preprints using CosMx
Who started using CosMx recently?
22 institutions posted their first preprint using CosMx since April 2025 in the last 6 months, including Imperial College London, University Medical Center Schleswig-Holstein, Lübeck Campus and Mahidol University.
Imperial College LondonJul 17, 2026
- University Medical Center Schleswig-Holstein, Lübeck CampusJun 6, 2026
Mahidol UniversityJun 29, 2026
University of LübeckJul 4, 2026
- Merck & Co., Inc.Jul 13, 2026
McGill UniversityJul 16, 2026
Moffitt Cancer CenterJul 20, 2026
Shandong UniversityJul 31, 2026
University of MinnesotaAug 10, 2026
Sir Run Run Shaw HospitalAug 11, 2026
An institution counts as new when its first preprint using CosMx since April 2025 was posted in the last 6 months; the date is that first preprint.
What do labs use alongside CosMx?
Preprints using CosMx most often also use Chromium, NovaSeq X and NextSeq. The count is preprints using both.
What is CosMx used for?
Preprints using CosMx are most often in cancer biology, neuroscience and genomics.
Fields
Cancer biology 23Neuroscience 14Genomics 12Immunology 11Bioinformatics 8Cell biology 7
Where the work was published
- Nature Communications2
- NAR Genomics and Bioinformatics1
- npj Parkinson's Disease1
- Journal of Neuroinflammation1
- Nature Aging1
- European Journal of Immunology1
How we count which preprints use each platform
An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.